Board of Directors
| PRESIDENT Ian MacKenzie |
|
| VICE PRESIDENT Richard J. Briscoe, Merck Research Laboratories |
|
| VICE-PRESIDENT ELECT Kristy Bruse, Independent Consultant/Associate Consultant with Paracelsus Inc. |
|
| SECRETARY JoAnne Saye, AstraZeneca Pharmaceuticals |
|
| SECRETARY-ELECT Paul C. Harrison, Boehringer Ingelheim Pharmaceuticals, Inc. |
|
| TREASURER Derek Leishman, Eli Lilly & Co. |
|
| DIRECTORS Marc Bailie, Michigan State University, Department. of Pharmacology |
|
| Alan Stuart Bass, Schering-Plough Research Institute | |
| Tom Beck, Covance Laboratories | |
| Henry Holzgrefe, Hoffmann-La Roche AG | |
| Mary Jeanne Kallman, Eli Lilly & Co. | |
| Leslie Patmore, Aptuit Consulting | |
| Alison Templeton, Aptuit | |
| Hugo Vargas, Amgen, Inc. | |
| Rob Wallis, Pfizer, Ltd. |
Announcements
Deadlines to Remember:
Advance Registration
August 21
Hotel Reservations
August 21
Cancellation Deadline
August 25